RizaMigren (rizatriptan) tablets 5 mg. #3

$13.60

Manufactured in: Ukraine

Rizamigren tablets are used to treat migraine attacks in adults by relieving symptoms such as headache, nausea, sensitivity to light, and sound, with a recommended dosage of one tablet at the onset of a migraine, up to a maximum of two tablets in a 24-hour period.

SKU: MED7592 Category:

Description

RizaMigren (Rizatriptan) Tablets 5 mg.

RizaMigren is a prescription medication that contains the active ingredient Rizatriptan. It is available in tablet form with a strength of 5 mg. Each pack contains 3 tablets. Rizatriptan is commonly used to treat migraines and their associated symptoms.

What is Rizatriptan?

Rizatriptan belongs to a class of drugs known as triptans. Triptans work by narrowing blood vessels in the brain and reducing the release of certain natural substances that cause migraine symptoms such as headache, nausea, sensitivity to light, and sound. Rizatriptan is specifically designed to target migraine headaches and relieve the pain and other symptoms associated with them.

Indications

RizaMigren tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. It is not intended for the prevention of migraines or the treatment of other types of headaches.

Dosage and Administration

The usual recommended dose of RizaMigren is one 5 mg. tablet taken orally with water at the onset of a migraine headache. If the migraine symptoms do not improve after the initial dose, a second tablet may be taken at least 2 hours after the first dose. Do not take more than 2 tablets in a 24-hour period.

If the migraine headache returns after an initial relief, a second dose may be taken as long as there is at least a 2-hour interval between doses. If the symptoms do not improve after the first dose, it is not recommended to take a second dose for the same attack.

Warnings and Precautions

Before taking RizaMigren, inform your healthcare provider if you have any of the following conditions:

  • History of heart disease or stroke
  • High blood pressure
  • Peripheral vascular disease
  • Severe liver or kidney disease
  • Uncontrolled hypertension
  • History of certain types of headaches (e.g., basilar or hemiplegic migraine)

It is important to follow the dosage instructions provided by your healthcare provider to avoid potential side effects and complications. Do not exceed the recommended dose or frequency of use.

Side Effects

Common side effects of RizaMigren may include:

  • Weakness or tiredness
  • Dizziness
  • Flushing
  • Nausea
  • Changes in heart rate

If you experience any severe side effects or allergic reactions such as difficulty breathing, swelling of the face, lips, throat, or tongue, seek immediate medical attention.

Drug Interactions

RizaMigren may interact with other medications, including:

  • Ergot-containing drugs
  • MAO inhibitors
  • Selective serotonin reuptake inhibitors (SSRIs)
  • Tricyclic antidepressants
  • Other triptans

Inform your healthcare provider about all the medications you are currently taking to prevent potential drug interactions and ensure the safe use of RizaMigren.

Storage

Store RizaMigren tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the tablets if they are past the expiration date or if the packaging is damaged.

Conclusion

RizaMigren tablets containing Rizatriptan 5 mg. are an effective treatment option for acute migraine attacks in adults. By following the prescribed dosage and administration guidelines, patients can experience relief from migraine symptoms and improve their quality of life. It is essential to be aware of the potential side effects, drug interactions, and precautions associated with RizaMigren to ensure its safe and effective use.

Always consult your healthcare provider before starting any new medication or changing your current treatment plan. If you have any questions or concerns about RizaMigren or its use, do not hesitate to seek guidance from a qualified healthcare professional.